{
  "title": "Large scale paired antibody language models",
  "url": "https://openalex.org/W4405104445",
  "year": 2024,
  "authors": [
    {
      "id": "https://openalex.org/A3015564182",
      "name": "Henry Kenlay",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2607902978",
      "name": "Frédéric A. Dreyer",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2771085006",
      "name": "Aleksandr Kovaltsuk",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A5094264779",
      "name": "Dom Miketa",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2074383188",
      "name": "Douglas Pires",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2051648533",
      "name": "Charlotte M. Deane",
      "affiliations": []
    }
  ],
  "references": [
    "https://openalex.org/W2088510308",
    "https://openalex.org/W2246074199",
    "https://openalex.org/W2603247627",
    "https://openalex.org/W2792924456",
    "https://openalex.org/W4283068487",
    "https://openalex.org/W6804449239",
    "https://openalex.org/W6852575741",
    "https://openalex.org/W4366998330",
    "https://openalex.org/W4280625391",
    "https://openalex.org/W4220757565",
    "https://openalex.org/W4317717793",
    "https://openalex.org/W2950118240",
    "https://openalex.org/W3206187363",
    "https://openalex.org/W2896457183",
    "https://openalex.org/W2981852735",
    "https://openalex.org/W4405104445",
    "https://openalex.org/W3146944767",
    "https://openalex.org/W4327550249",
    "https://openalex.org/W3177500196",
    "https://openalex.org/W4318071656",
    "https://openalex.org/W4309506674",
    "https://openalex.org/W4213149192",
    "https://openalex.org/W4210494137",
    "https://openalex.org/W2965373594",
    "https://openalex.org/W4393950286",
    "https://openalex.org/W4391738021",
    "https://openalex.org/W4289782607",
    "https://openalex.org/W4315588295",
    "https://openalex.org/W4383550741",
    "https://openalex.org/W6739901393",
    "https://openalex.org/W2102461176",
    "https://openalex.org/W2949342052",
    "https://openalex.org/W2953008890",
    "https://openalex.org/W2950954328",
    "https://openalex.org/W3129831491",
    "https://openalex.org/W2560647685",
    "https://openalex.org/W3104215796",
    "https://openalex.org/W2969325782",
    "https://openalex.org/W2570949719",
    "https://openalex.org/W3156636935",
    "https://openalex.org/W4389028818",
    "https://openalex.org/W4390649554",
    "https://openalex.org/W6796581206",
    "https://openalex.org/W4366823175",
    "https://openalex.org/W6857357817",
    "https://openalex.org/W4288089799",
    "https://openalex.org/W4200079908",
    "https://openalex.org/W3168867926",
    "https://openalex.org/W4387667139"
  ],
  "abstract": "Antibodies are proteins produced by the immune system that can identify and neutralise a wide variety of antigens with high specificity and affinity, and constitute the most successful class of biotherapeutics. With the advent of next-generation sequencing, billions of antibody sequences have been collected in recent years, though their application in the design of better therapeutics has been constrained by the sheer volume and complexity of the data. To address this challenge, we present IgBert and IgT5, the best performing antibody-specific language models developed to date which can consistently handle both paired and unpaired variable region sequences as input. These models are trained comprehensively using the more than two billion unpaired sequences and two million paired sequences of light and heavy chains present in the Observed Antibody Space dataset. We show that our models outperform existing antibody and protein language models on a diverse range of design and regression tasks relevant to antibody engineering. This advancement marks a significant leap forward in leveraging machine learning, large scale data sets and high-performance computing for enhancing antibody design for therapeutic development.",
  "full_text": null,
  "topic": "Computer science",
  "concepts": [
    {
      "name": "Computer science",
      "score": 0.6818143129348755
    },
    {
      "name": "Variety (cybernetics)",
      "score": 0.5371025800704956
    },
    {
      "name": "Scale (ratio)",
      "score": 0.523807168006897
    },
    {
      "name": "Antibody",
      "score": 0.5188332796096802
    },
    {
      "name": "Class (philosophy)",
      "score": 0.4565931558609009
    },
    {
      "name": "Artificial intelligence",
      "score": 0.43826180696487427
    },
    {
      "name": "Range (aeronautics)",
      "score": 0.41353175044059753
    },
    {
      "name": "Computational biology",
      "score": 0.4118489623069763
    },
    {
      "name": "Machine learning",
      "score": 0.35258418321609497
    },
    {
      "name": "Biology",
      "score": 0.22023072838783264
    },
    {
      "name": "Immunology",
      "score": 0.17322632670402527
    },
    {
      "name": "Composite material",
      "score": 0.0
    },
    {
      "name": "Physics",
      "score": 0.0
    },
    {
      "name": "Quantum mechanics",
      "score": 0.0
    },
    {
      "name": "Materials science",
      "score": 0.0
    }
  ],
  "institutions": [
    {
      "id": "https://openalex.org/I4210091060",
      "name": "Bioscientifica (United Kingdom)",
      "country": "GB"
    },
    {
      "id": "https://openalex.org/I40120149",
      "name": "University of Oxford",
      "country": "GB"
    }
  ],
  "cited_by": 33
}